Following InterMed’s dynamic participation at AEEDC Dubai -one of the largest and most internationally recognized events for the dental community- where it actively contributed to the scientific program with a lecture on dental implants that attracted strong attendance and significant scientific interest, the Tsetis Pharmaceutical Group of Companies marked its presence at another leading international healthcare event in the Middle East, WHX Dubai (formerly Arab Health). For more than 50 years, this exhibition has served as a key global meeting point, bringing together healthcare professionals from around the world in Dubai.

It is worth noting that the Tsetis Group, with UNI-PHARMA and InterMed, was the only Greek pharmaceutical group to participate this year as an exhibitor at this major event, the largest healthcare exhibition in the wider Middle East region.

UNI-PHARMA and InterMed presented an expanded portfolio of innovative pharmaceutical products, OTC medicines, medical devices, dermocosmetics, and food supplements, designed to address modern needs in prevention, therapeutic support, and overall wellbeing.

Guided by scientific documentation, quality, safety, and the promotion of patient compliance with treatment, UNI-PHARMA and InterMed products contribute meaningfully to improving quality of life, supporting prevention, and encouraging responsible self-care.

WHX Dubai is one of the most significant international gatherings in the fields of healthcare, pharmaceuticals, and medical technology and is held annually in Dubai. The event brings together healthcare professionals, companies, and institutional stakeholders from across the globe, offering a dynamic environment for knowledge exchange, the presentation of innovative solutions, and the development of international partnerships. This year’s exhibition (2026) hosted more than 4,300 exhibitors from 180 countries and attracted over 235,000 visitors.

The Tsetis Group strengthened presence in the Middle East confirms the Group’s outward-looking growth strategy, with a focus on sustainable development, international collaboration, and responsible entrepreneurship.

UNI-PHARMA and InterMed promote access to reliable, high-quality, and innovative healthcare solutions, contributing positively to both local communities and the broader global healthcare ecosystem.